BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33336328)

  • 1. Fatal Disseminated Intravascular Coagulopathy in Covid-19: A Small Case Series.
    Kazmi S; Herekar F; Sarfaraz S
    Semin Thromb Hemost; 2021 Jun; 47(4):427-430. PubMed ID: 33336328
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness.
    Lippi G; Henry BM; Sanchis-Gomar F
    Semin Thromb Hemost; 2021 Jun; 47(4):460-462. PubMed ID: 33378783
    [No Abstract]   [Full Text] [Related]  

  • 3. Complement activation and coagulopathy - an ominous duo in COVID19.
    Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
    Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study.
    Muñoz-Rivas N; Abad-Motos A; Mestre-Gómez B; Sierra-Hidalgo F; Cortina-Camarero C; Lorente-Ramos RM; Torres-Rubio P; Arranz-García P; Franco-Moreno AI; Gómez-Mariscal E; Mauleón-Fernández C; Alonso-García S; Rogado J; Saez-Vaquero T; Such-Diaz A; Ryan P; Moya-Mateo E; Martín-Navarro JA; Hernández-Rivas JA; Torres-Macho J; Churruca J;
    Thromb Res; 2021 Mar; 199():132-142. PubMed ID: 33503547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19-related laboratory coagulation findings.
    Devreese KMJ
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):36-42. PubMed ID: 34288440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19-associated coagulopathy and disseminated intravascular coagulation.
    Asakura H; Ogawa H
    Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology.
    Chekkal M; Deba T; Hadjali S; Lamara H; Oulaa H; Zouai K; Hariti G
    Transfus Clin Biol; 2020 Nov; 27(4):203-206. PubMed ID: 33022374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II.
    Favaloro EJ; Lippi G
    Semin Thromb Hemost; 2021 Jun; 47(4):333-337. PubMed ID: 34062596
    [No Abstract]   [Full Text] [Related]  

  • 9. Coagulation changes and thromboembolic risk in COVID-19 obstetric patients.
    Benhamou D; Keita H; Ducloy-Bouthors AS;
    Anaesth Crit Care Pain Med; 2020 Jun; 39(3):351-353. PubMed ID: 32437961
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation.
    Takahashi W; Yoneda T; Koba H; Ueda T; Tsuji N; Ogawa H; Asakura H
    Int J Infect Dis; 2021 Jan; 102():529-531. PubMed ID: 33157292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 versus HIT hypercoagulability.
    Warkentin TE; Kaatz S
    Thromb Res; 2020 Dec; 196():38-51. PubMed ID: 32841919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of disseminated intravascular coagulation in COVID-19 patients: a scoping review.
    Mori H; Ohkawara H; Togawa R; Rikimaru M; Shibata Y; Ikezoe T
    Int J Hematol; 2021 Mar; 113(3):320-329. PubMed ID: 33550533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation.
    Iba T; Levy JH; Warkentin TE; Thachil J; van der Poll T; Levi M;
    J Thromb Haemost; 2019 Nov; 17(11):1989-1994. PubMed ID: 31410983
    [No Abstract]   [Full Text] [Related]  

  • 14. Coagulation abnormalities and thrombosis in patients with COVID-19.
    Levi M; Thachil J; Iba T; Levy JH
    Lancet Haematol; 2020 Jun; 7(6):e438-e440. PubMed ID: 32407672
    [No Abstract]   [Full Text] [Related]  

  • 15. [Peculiarities of blood coagulation disorders in patients with COVID-19].
    Evtugina NG; Sannikova SS; Peshkova AD; Safiullina SI; Andrianova IA; Tarasova GR; Khabirova AI; Rumyantsev AG; Ataullakhanov FI; Litvinov RI
    Ter Arkh; 2021 Nov; 93(11):1255-1263. PubMed ID: 36286646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19: Thrombosis, thromboinflammation, and anticoagulation considerations.
    Levy JH; Iba T; Olson LB; Corey KM; Ghadimi K; Connors JM
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):29-35. PubMed ID: 34288441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboelastography-Guided Management of Anticoagulated COVID-19 Patients to Prevent Hemorrhage.
    Stillson JE; Bunch CM; Gillespie L; Khan R; Wierman M; Pulvirenti J; Phyu H; Anderson S; Al-Fadhl M; Thomas AV; Kwaan HC; Moore E; Moore H; Walsh MM
    Semin Thromb Hemost; 2021 Jun; 47(4):442-446. PubMed ID: 33607668
    [No Abstract]   [Full Text] [Related]  

  • 18. A unique tale of COVID-19 induced concomitant overt disseminated intravascular coagulation and acute bilateral pulmonary embolism.
    Siddiqui SN; Jayasekhar R; Tshering S; Jugjali R; Shanmugavadivel D; Jawed A; Rahman MM
    Int J Infect Dis; 2021 Mar; 104():568-571. PubMed ID: 33486013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 coagulopathy: an evolving story.
    The Lancet Haematology
    Lancet Haematol; 2020 Jun; 7(6):e425. PubMed ID: 32470428
    [No Abstract]   [Full Text] [Related]  

  • 20. Coagulation and anticoagulation in COVID-19.
    Hadid T; Kafri Z; Al-Katib A
    Blood Rev; 2021 May; 47():100761. PubMed ID: 33067035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.